Daclizumab, an efficient treatment for steroid-refractory acute graft-versus-host disease

British Journal of Haematology

Volumn 135, Issue 3, 2006, Pages 382-385

  Bordigoni, Pierre ^a   Dimicoli, Sophie ^a   Clement, Laurence ^a   Baumann, Cédric ^b   Salmon, Alexandra ^a   Witz, Francis ^a   Feugier, Pierre ^a  

^a HÔPITAL D ENFANTS   (France)

^b INSERM   (France)

Author keywords

Allogeneic stem cell transplantation; Daclizumab; Steroid refractory acute graft versus host disease

Indexed keywords

CYCLOSPORIN A; DACLIZUMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SURVIVAL RATE; VIRUS INFECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33749253337     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06321.x     Document Type: Article

References (11)

1. Antin, J.H., Chen, A.R., Couriel, D.R., Ho, V.T., Nash, R.A. & Weisdorf, D. (2004). Novel approaches to the therapy of steroid-resistant acute graft-versus-host-disease. Biology of Blood and Marrow Transplantation, 10, 655-668.
2. Bay, J.O., Dhédin, N., Goerner, M., Vannier, J.P., Marie-Cardine, A., Stamatoullas, A., Jouet, J.P., Yakoub-Agha, I., Tabrizi, R., Faucher, C., Diez-Martin, J.L., Nunez, G., Parody, R., Milpied, N., Espérou, H., Garban, F., Galambrun, C., Kwiatkovski, F., Darlavoix, I., Zinaï, A., Fischer, A., Michallet, M. & Vernant, J.P. (2005). Inolimomab in steroid-refractory acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: retrospective analysis and comparison with other Interleukin-2 receptor antibodies. Transplantation, 80, 782-788.
3. Greinix, H.T., Knobler, R.M., Worel, N., Schneider, B., Schneeberger, A., Hoecker, P., Mitterbauer, M., Rabitsch, W., Schulenburg, A. & Kalhs, P. (2006). The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease. Haematologica, 91, 405-408.
4. Lee, S.J., Zahrieh, D., Agura, E., MacMillan, M.L., Maziarz, R.T., McCarthy, P.L., Ho, V.T., Cutler, C., Alyea, E.P., Antin, J.H. & Soiffer, R.J. (2004). Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial. Blood, 104, 1559-1564.
5. Martin, P.J., Schoch, G., Fisher, L., Byers, V., Appelbaum, F.R., McDonald, G.B., Storb, R. & Hansen, J.A. (1991). A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood, 77, 1821-1828.
6. Patriarca, F., Sperotto, A., Damiani, D., Morreale, G., Bonifazi, F., Olivieri, A., Ciceri, F., Milone, G., Cesaro, S., Bandini, G., Dini, G., Corradini, P. & Fanin, R. (2004). Infliximab treatment for steroid-refractory acute graft-versus-host disease. Haematologica, 89, 1352-1359.
7. Przepiorka, D., Kernan, N.A., Ippoliti, C., Papadopoulos, E.B., Giralt, S., Khouri, I., Lu, J.G., Gajewski, J., Durett, A., Cleary, K., Champlin, R., Andersson, B.S. & Light, S. (2000). Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood, 95, 83-89.
8. Schmidt-Hieber, M., Fietz, T., Knauf, W., Uharek, L., Hopfenmüller, W., Thiel, E. & Blau, I.W. (2005). Efficacy of the interleukin-2 receptor antagonist basiliximab in steroid-refractory acute graft-versus-host disease. British Journal of Haematology, 10, 1365-2141.
9. Srinivasan R., Chakrabarti S., Walsh T., Igarashi T., Takahashi Y., Kleiner D., Donohue T., Shalabi R., Carvallo C., Barrett A.J., Geller N & Childs, R. (2004). Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis. British Journal of Haematology, 10, 1365-2141.
10. Teachey, D.T., Bickert, B. & Bunin, N. (2006). Daclizumab for children with corticosteroid-refractory graft-versus-host disease. Bone Marrow Transplantation, 37, 95-99.
11. Willenbacher, W., Basara, N., Blau, I.W., Fauser, A.A. & Kiehl, M.G. (2001). Treatment of steroid- refractory acute and chronic graft-versus-host disease with daclizumab. British Journal of Haematology, 112, 820-823.